Details
New companies 3 · Follow-on 0
Stages: Series C+ 2, Seed 1
Harvey $550M Series HEtched $700M Series DDecade $85M SeedRanked by rounds participated in, from announcements in Jul 23, 2026 – Oct 20, 2026. Lead counts include only confirmed lead roles.
New companies 3 · Follow-on 0
Stages: Series C+ 2, Seed 1
Harvey $550M Series HEtched $700M Series DDecade $85M SeedNew companies 3 · Follow-on 0
Stages: Pre-seed 2, Seed 1
Dynamic Creatures Undisclosed SeedLimetax €36M Pre-seed equity and acquisition facilitysci2sci €1.2M Pre-SeedNew companies 2 · Follow-on 1
Stages: Series A 3
TwoStep Therapeutics $62.5M Series AStarcloud $250M Series A extensionRemepy $36M Series ANew companies 3 · Follow-on 0
Stages: Series A 2, Seed 1
VideoGen $3.3M SeedHenry AI $16.5M Series AHealia $14M Series ANew companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Carrum Mobility $10M Series BGalgo Undisclosed Strategic investmentMoove $250M Series CNew companies 3 · Follow-on 0
Stages: Series B 3
Gimlet Labs $300M Series BPoint2 Technology $136M Series BOlix $312M Series BNew companies 3 · Follow-on 0
Stages: Undisclosed 3
3Sonic €1.3M BII additional fundingSagava €1.3M Venture House follow-on fundingYngvi Bio €1.3M BII Venture House convertible loanNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series A 1
Fab2 $500M Series AEpicrispr Biotechnologies $90M Series CRatio Therapeutics $70M Series CNew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Undisclosed 1
Blee $20M Series AUpwind Security ~$300M FundingSiteVue AI $7.5M SeedNew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Series B 1
Gimlet Labs $300M Series BWafer $40M Series ASynthefy $6.5M SeedNew companies 2 · Follow-on 1
Stages: Growth 1, Series A 1, Series C+ 1
Lyte $165M Series CRemepy $36M Series AXsight Labs >$300M GrowthNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series B 1
Thyme Care >$125M Series EAbcuro $66M Series DKhartis Therapeutics $50M Series BNew companies 3 · Follow-on 0
Stages: Growth 2, Series B 1
TabaPay $155M Series B strategic growth financingKingsview Partners Undisclosed GrowthCOR $30M GrowthNew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
Odyssey Energy Solutions $74M FundingLight $46M Series AReservoir $8M SeedNew companies 3 · Follow-on 0
Stages: Seed 2, Pre-seed 1
The Interaction Company of California $15M SeedLegato $12M SeedCast Insights $4.5M Pre-SeedNew companies 3 · Follow-on 0
Stages: Series C+ 2, Undisclosed 1
Cyclic Materials $75M StrategicCastelion $1B Series CK2 Space $500M Series DNew companies 3 · Follow-on 0
Stages: Series A 2, Series C+ 1
AusperBio $120M Series CBeyang Therapeutics $30M Series ACORE Biomedicine $21M Series ANew companies 3 · Follow-on 0
Stages: Series C+ 2, Series A 1
Voya Energy $35M Series AHopscotch Primary Care $53M Series DAntora Energy $550M Series CNew companies 2 · Follow-on 1
Stages: Growth 1, Series C+ 1, Undisclosed 1
Blank Street $75M Series CIceye €1B UndisclosedGravie Undisclosed GrowthNew companies 3 · Follow-on 0
Stages: Seed 2, Series A 1
Medly AI $8M SeedIntropy $11M SeedThrone Science $10M Series ANew companies 3 · Follow-on 0
Stages: Series C+ 3
Castelion $1B Series CHadrian $1.4B Series DBase Power $1B Series DNew companies 3 · Follow-on 0
Stages: Series A 2, Series C+ 1
Velaura AI $110M Series ALumilens >$700M Series CSmallest.ai $13M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Hunar.AI ₹393M Series AFurnishka ~₹268M Extended pre-Series ANew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Nouscom €120M Series DHighLife €80M Financing roundNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Hunar.AI ₹393M Series ARocketPay ₹100M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Nouscom €120M Series DVaderis Therapeutics $152M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Linkener €7.5M Equity fundingAeon Undisclosed Seed extensionNew companies 2 · Follow-on 0
Stages: Series A 2
Hunar.AI ₹393M Series AFurnishka ~₹268M Extended pre-Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.